Bliss GVS Pharma Ltd
₹425.30
(7.17%)
Sun, 31 May 2026, 01:12 pm
Health Technology
Pharmaceuticals: Major
24.5KBliss GVS Pharma Share Price Live Chart
1 Day
(7.17%)
No Result Found
Summary
Market Cap
4493.92
Net Profit
90.26
P/B
1.18
Sector P/E
33.76
P/E
14.69
EV/EBITDA
6.82
Debt/Equity (Industry)
0.26
Interest Cover (Industry)
10.81
ROCE (Industry)
16.40
RONW (Industry)
14.39
ROE
8.95
ROCE
12.09
Debt/Equity
0.09
EPS (TTM)
12.36
Dividend Yield
0.24
Book Value
112.76
Interest Cover
16.47
Analysis
all
- Dividends per share have increased over the past 10 years.
- Dividends paid are thoroughly covered by earnings (10.3x coverage).
- Bliss GVS Pharma's pays a higher dividend yield than the bottom 25% of dividend payers in India (0.76%).
- Bliss GVS Pharma is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Bliss GVS Pharma is profitable, therefore cash runway is not a concern.
- Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
- Bliss GVS Pharma's dividend is below the markets top 25% of dividend payers in India (3.08%).
- High level of physical assets or inventory.
- Shibroor's remuneration is higher than average for companies of similar size in India.
- Bliss GVS Pharma is not covered by any analysts.
Shareholding
| Shareholders | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 |
|---|---|---|---|---|---|
| Promoters | 35.36 | 35.36 | 35.39 | 35.44 | 35.29 |
| FII | 10.45 | 14.54 | 13.27 | 12.65 | 13.18 |
| DII | 5.04 | 5.78 | 5.98 | 6.54 | 6.55 |
| Public | 49.15 | 44.32 | 45.36 | 45.36 | 44.98 |
| Government | 0 | 0 | 0 | 0 | 0 |
Technical Analysis
Support and Resistance
| Type | R3 | R2 | R1 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 380.75 | 320.05 | 298.41 | 259.35 | 237.71 | 198.65 | 137.95 |
| Fibonacci | 320.05 | 296.87 | 282.54 | 259.35 | 236.17 | 221.84 | 198.65 |
| Camarilla | 293.45 | 287.89 | 282.32 | 259.35 | 271.20 | 265.63 | 260.07 |
Pivots Level: Classic
R3
+121.40
380.75
R2
+60.70
320.05
R1
+39.05
298.41
S1
-21.65
237.71
S2
-60.70
198.65
S3
-121.40
137.95
Moving Average
Period
Value
10-EMA
342.73
20-EMA
312.96
30-EMA
296.28
50-EMA
274.09
100-EMA
241.04
200-EMA
208.04
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 12 May 2026 | agm | ||
| 12 May 2026 | board-meetings | Accounts, Final Dividend | |
| 10 Feb 2026 | board-meetings | Quarterly Results, Interim Dividend | |
| 10 Feb 2026 | dividend | ₹0.50 Dividend /Share | 18 Feb 2026 |
| 18 Jan 2026 | dividend | Interim Dividend - Re 0.50 Per Share | 18 Feb 2026 |
| 06 Nov 2025 | board-meetings | Quarterly Results | |
| 24 Jun 2025 | dividend | Final Dividend - Rs. - 0.5 | 24 Jul 2025 |
| 12 May 2025 | agm | ||
| 12 May 2025 | dividend | ₹0.50 Dividend /Share | 24 Jul 2025 |
| 18 Jun 2024 | dividend | Annual General Meeting/Dividend - Rs 0.50 Per Share | 19 Jul 2024 |
Peer Comparison
Bliss GVS Pharma Ltd
Dr Reddys Laboratories Ltd
Sun Pharmaceutical Industries Ltd
Torrent Pharmaceuticals Ltd
Divis Laboratories Ltd
Cipla Ltd
Bliss GVS Pharma Ltd About
Bliss GVS Pharma is engaged in manufacturing, marketing, trading and export of pharmaceutical products. The Company is one of among the world leaders in Suppositories and Pessaries dosage forms with one of the largest portfolios in this segment.
Industry
Pharmaceuticals - Indian - Formulations
Founded
1984
Headquarters
CEO
Nandkumar Kashinath Chodankar
Employees
Contact
Website
http://www.blissgvs.com
cs@blissgvs.com; info@blissgvs.com
Phone
91-22-42160000
Location
102 Hyde Park Sakivihar Road, Andheri East, Mumbai, Maharashtra, 400072
Bliss GVS Pharma Ltd Company History
| Year | History |
|---|---|
| 2012 |
|
| 2013 |
|
| 2014 |
|
| 2015 |
|
| 2016 |
|
Deals
| Client Name | Deal Type | Order Side | QTY | Avg Price | Date |
|---|---|---|---|---|---|
| HRTI PRIVATE LIMITED | bulk | Buy | 457998 | 419.26 | 29 May 2026 |
| HRTI PRIVATE LIMITED | bulk | Sell | 562933 | 420.49 | 29 May 2026 |
| SHAILESH SHIVKUMAR DALMIA | bulk | Sell | 1008910 | 317.64 | 25 May 2026 |
| HRTI PRIVATE LIMITED | bulk | Buy | 517506 | 224.26 | 25 Mar 2026 |
| HRTI PRIVATE LIMITED | bulk | Sell | 581292 | 224.86 | 25 Mar 2026 |
| RATNABALI EQUITY PRIVATE LIMITED | bulk | Buy | 717000 | 212.56 | 20 Mar 2026 |
| RATNABALI EQUITY PRIVATE LIMITED | bulk | Sell | 717102 | 212.11 | 20 Mar 2026 |
| ARIAN INVESTMENT LTD | bulk | Sell | 1000000 | 210.82 | 19 Mar 2026 |
| MATEUS LTD | bulk | Buy | 933978 | 210.81 | 19 Mar 2026 |
| MANSUKH SECURITIES & FINANCE LIMITED | bulk | Buy | 620900 | 220.81 | 24 Feb 2026 |